ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0940

In Patients with Inflammatory Arthritides Central Pain Sensitization Is Strictly Associated with Functional Disability

Giovanni Adami1, Angelo Fassio1, Elisabetta Gerratana2, Alessandro Giollo1, Camilla Benini1, Luca Idolazzi1, Elisabetta Vantaggiato1, Davide Gatti1 and Maurizio Rossini1, 1Rheumatology Unit, University of Verona, Verona, Italy, 2Rheumatology Unit, University of Messina, Messina, Italy

Meeting: ACR Convergence 2020

Keywords: Disease Activity, pain, Psoriatic arthritis, rheumatoid arthritis, Synovitis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Fibromyalgia & Other Clinical Pain Syndromes (0940–0944)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Long-term nociceptive pain, as in inflammatory arthritides, can cause Central Sensitization (CS) to pain. CS Inventory (CSI) is a validated screening instrument for clinicians to help identifying patients with CS. We sought to investigate the association between CSI score and clinical, demographic and ultrasonographic parameters of patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA)

Methods: We conducted a cross-sectional analysis on patients with an established diagnosis of RA or polyarticular PsA. Disease activity was measured with SDAI and DAS28-CRP in RA patients and with DAPSA in PsA patients. The presence and severity of synovitis was also measured with the overall ultrasound (US) 7-joints score and its components (gray-scale ultrasound [GSUS], power-Doppler ultrasound [PDUS] and erosions). CSI questionnaire was analyzed either as a continuous variable or as positiveegative (threshold 40 points) or divided in four categories, i.e., subclinical (≤29), mild (30-39), moderate (40-49), severe/extreme (≥50). Exclusion criteria included: diagnosis of PsA with enthesitis predominant and/or spondylitis subtypes.

Results: A multiple linear regression analysis was performed to predict CSI score based on clinical and demographic characteristics (age, sex, BMI, disease duration, tender and swollen joints, CRP, 7-joints US score and fibromyalgia diagnosis), including HAQ. HAQ was the only significant predictor of the CSI score (figure 1 and 2). CSI score increased of 15.3 points for each point of HAQ (95% CI 7.4-23.3, p < 0.0001). In PsA patients, but not in RA patients, disease activity was strongly correlated with CSI score (figure 3).

Overall, we did not find any correlation between 7-joints US score and CSI score. We found a significant association between 7-joints US score (and its components) and disease duration (year to diagnosis r 0.53, p < 0.0001), interestingly, only the erosion score correlated significantly with the time from symptoms onset to the diagnosis (0.28, p < 0.01). In subgroups analyses, in patients with RA, 7-joints US overall score was positively associated with disease duration (years to onset of symptoms r 0.77, p < 0.0001). We found a strong relationship between 7-joints overall, PDUS scores and disease activity scores of RA (r 0.50 p 0.006 for SDAI and PDUS). In PsA patients, we found no association between 7-joints US overall, GSUS, PDUS or erosion score and DAPSA.

Conclusion: In summary, central sensitization assessed with CSI questionnaire was significantly associated with functional disability measured with HAQ independently from age, sex, BMI, concomitant fibromyalgia diagnosis and other clinical parameters (CRP, time to disease onset, tender and swollen joint count). SDAI and DAS28-CRP were significantly associated with ultrasonographic parameters of synovial inflammation.

Figure 1. Relationship between HAQ and CSI questionnaire score in patients with inflammatory arthritides. R2 0.361, p < 0.0001

Figure 2. Median HAQ at different CSI questionnaire score ranges

Figure 3. Relationship between DAPSA and CSI questionnaire score in patients with psoriatic arthritis. R2 0.436, p < 0.0001


Disclosure: G. Adami, None; A. Fassio, None; E. Gerratana, None; A. Giollo, None; C. Benini, None; L. Idolazzi, None; E. Vantaggiato, None; D. Gatti, None; M. Rossini, None.

To cite this abstract in AMA style:

Adami G, Fassio A, Gerratana E, Giollo A, Benini C, Idolazzi L, Vantaggiato E, Gatti D, Rossini M. In Patients with Inflammatory Arthritides Central Pain Sensitization Is Strictly Associated with Functional Disability [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/in-patients-with-inflammatory-arthritides-central-pain-sensitization-is-strictly-associated-with-functional-disability/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-patients-with-inflammatory-arthritides-central-pain-sensitization-is-strictly-associated-with-functional-disability/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology